3
Oct 20 (Reuters) – Verrica Pharmaceuticals Inc: * VERRICA PHARMACEUTICALS RECEIVES POSITIVE FEEDBACK FROM THE EUROPEAN MEDICINES AGENCY (EMA) SUPPORTING A CLEAR REGULATORY PATH FORWARD TO FILE FOR APPROVAL OF YCANTH® IN THE EUROPEAN UNION * VERRICA PHARMACEUTICALS INC – PLANS REGULATORY SUBMISSION FOR YCANTH BY Q4 2026 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
